// App-Quantinova.ai

B20 : Generation of Autologous CMV and EBV-Specific T-Cell Lines from Seronegative Patients for Cell Therapy of Opportunistic Infections Following Kidney Transplantation.

Researchers

Presenter

  • C. Lamarche

Principal Investigators

  • T. Pincez

  • J. Orio

  • C. Carli

  • A. Humar

  • J.-S. Delisle

Medical Centers

  • Centre de Recherche Hopital Maissoneuve-Rosemont, Montreal, Quebec, Canada.

  • Toronto General Hospital/Research Institute (UHN), Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • N/A

Biomarkers

  • Peripheral blood mononuclear cell

  • Cluster of Differentiation 4

  • Cluster of differentiation 8A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved